Employees Retirement System of Texas cut its holdings in Stryker Corporation (NYSE:SYK – Free Report) by 1.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 197,000 shares of the medical technology company’s stock after selling 3,200 shares during the quarter. Employees Retirement System of Texas’ holdings in Stryker were worth $69,240,000 at the end of the most recent quarter.
Several other institutional investors have also recently modified their holdings of SYK. Czech National Bank grew its holdings in shares of Stryker by 3.9% during the fourth quarter. Czech National Bank now owns 90,755 shares of the medical technology company’s stock worth $31,898,000 after buying an additional 3,366 shares in the last quarter. Davis R M Inc. lifted its stake in shares of Stryker by 1.8% during the third quarter. Davis R M Inc. now owns 138,732 shares of the medical technology company’s stock valued at $51,285,000 after buying an additional 2,512 shares during the period. Terra Alpha Investments LLC acquired a new stake in Stryker during the third quarter worth approximately $1,216,000. Kepler Cheuvreux Suisse SA acquired a new stake in Stryker during the third quarter worth approximately $27,952,000. Finally, Daymark Wealth Partners LLC grew its stake in Stryker by 436.0% in the 4th quarter. Daymark Wealth Partners LLC now owns 45,863 shares of the medical technology company’s stock worth $16,119,000 after acquiring an additional 37,307 shares during the period. 77.09% of the stock is currently owned by institutional investors and hedge funds.
Stryker Stock Performance
Stryker stock opened at $313.08 on Wednesday. The company has a market cap of $120.02 billion, a price-to-earnings ratio of 36.24, a price-to-earnings-growth ratio of 1.99 and a beta of 0.80. Stryker Corporation has a 12 month low of $281.00 and a 12 month high of $404.87. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.11 and a quick ratio of 1.25. The stock’s 50-day moving average is $324.33 and its 200-day moving average is $349.12.
Stryker Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Tuesday, June 30th will be given a $0.88 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $3.52 annualized dividend and a dividend yield of 1.1%. Stryker’s dividend payout ratio is presently 40.74%.
Insider Activity
In other news, VP M Kathryn Fink sold 3,500 shares of the firm’s stock in a transaction on Monday, May 11th. The shares were sold at an average price of $283.45, for a total value of $992,075.00. Following the transaction, the vice president owned 177 shares of the company’s stock, valued at approximately $50,170.65. This trade represents a 95.19% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. 4.60% of the stock is owned by insiders.
Wall Street Analysts Forecast Growth
A number of brokerages have weighed in on SYK. Jefferies Financial Group reissued a “buy” rating and set a $465.00 price target on shares of Stryker in a research note on Wednesday, March 4th. Wells Fargo & Company lowered their price objective on Stryker from $456.00 to $418.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. Sanford C. Bernstein set a $410.00 target price on Stryker in a research note on Friday, May 1st. JPMorgan Chase & Co. decreased their price target on Stryker from $445.00 to $400.00 and set an “overweight” rating on the stock in a research note on Friday, May 1st. Finally, Robert W. Baird set a $385.00 price target on Stryker in a report on Friday, May 1st. Sixteen analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $395.48.
Check Out Our Latest Analysis on SYK
About Stryker
Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.
Read More
- Five stocks we like better than Stryker
- Banks Are Buying Back Stock Hand Over Fist, Including These 3 Names
- 2 Aluminum Stocks Poised for Big Tariff-Related Gains
- AutoZone’s Pullback Sets Up a Long-Term Buying Opportunity
- AST SpaceMobile’s June Launch Plan Puts Its 2026 Satellite Goal Back in Focus
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK – Free Report).
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.
